NCT01564199View on ClinicalTrials.gov

Phase I Pharmacokinetic Study (SALBLOCK)

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Healthy Volunteer Study
Interventions
DRUG

salmeterol / fluticasone propionate

100/1000 μg oral capsule

Trial Locations (1)

Unknown

CRST (Clinical Research Services Turku), Turku

All Listed Sponsors
lead

Orion Corporation, Orion Pharma

INDUSTRY

NCT01564199 - Phase I Pharmacokinetic Study (SALBLOCK) | Biotech Hunter | Biotech Hunter